Tüm alıştırma soruları

4736 soru

Soru 101Soru →

A 2222-year-old man with type 1 diabetes mellitus is being treated in the intensive care unit for diabetic ketoacidosis. He has been receiving a continuous intravenous regular insulin infusion, intravenous fluids, and potassium replacement for the past 1414 hours. Current laboratory evaluation reveals a blood glucose of 178178 mg/dL, a serum bicarbonate of 2020 mEq/L, and a calculated anion gap of 99 mEq/L. The patient is awake, alert, and reports feeling hungry. The physician decides to transition the patient to a subcutaneous insulin regimen. Arrange the following management and monitoring steps in the correct chronological sequence to safely accomplish this therapeutic de-escalation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with verifying diabetic ketoacidosis resolution, followed by administering subcutaneous basal insulin, maintaining an overlap with the intravenous insulin for 11 to 22 hours, discontinuing the intravenous infusion, and finally initiating routine preprandial monitoring.
The successful treatment of diabetic ketoacidosis requires a carefully monitored transition from continuous intravenous insulin to intermittent subcutaneous insulin. The protocol dictates that the physician must first confirm resolution of the ketoacidosis (anion gap ≤12\leq 12 mEq/L) and ensure the patient can tolerate oral intake. Because intravenous insulin clears the body within minutes and subcutaneous insulin takes 11 to 22 hours to begin working, subcutaneous basal insulin must be administered while the intravenous infusion is still running. This 11 to 22 hour overlap is critical to prevent a gap in insulin coverage, which would cause rapid rebound ketoacidosis. Only after this overlap period is complete should the intravenous infusion be discontinued. Finally, the patient is transitioned to routine maintenance monitoring, typically involving blood glucose checks before meals and at bedtime.

Adım Adım Çözüm

1
Assess clinical and laboratory criteria for diabetic ketoacidosis resolution.
The anion gap is closed (99 mEq/L) and the patient is able to eat.
Ensures that transitioning off continuous insulin is safe and physiologically appropriate.
2
Administer subcutaneous long-acting basal insulin.
A long-acting insulin depot is established in the subcutaneous tissue.
Provides baseline insulin coverage to prevent rebound hyperglycemia.
3
Overlap the intravenous and subcutaneous insulin for 11 to 22 hours.
Continuous insulin coverage is maintained during subcutaneous absorption.
Subcutaneous insulin takes time to reach systemic circulation and take effect.
4
Stop the continuous intravenous regular insulin infusion.
The patient is completely transitioned to subcutaneous insulin.
Intravenous insulin is no longer needed once the subcutaneous depot is active.
5
Transition to standard inpatient glycemic monitoring.
Blood glucose is checked before meals and at bedtime.
Allows for ongoing monitoring and administration of short-acting nutritional/correctional insulin.

Anahtar Kavram

Therapeutic De-escalation Protocol for Diabetic Ketoacidosis
Soru 102Soru →

A 58-year-old man is brought to the emergency department by his wife due to fever, severe headache, and confusion that started 12 hours ago. He has a past medical history of alcohol use disorder, type 2 diabetes mellitus, and hypertension. His temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, and heart rate is 115/min. On physical examination, he is lethargic but arousable. There is significant resistance to passive neck flexion. Funduscopic examination shows no papilledema. Lumbar puncture is performed, and cerebrospinal fluid (CSF) analysis reveals a leukocyte count of 2,400/mm³ (90% neutrophils), a glucose level of 30 mg/dL, and a protein level of 150 mg/dL. Gram stain of the CSF is pending.

Which of the following pharmacologic agents should be included in his immediate empiric regimen? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Ampicillin; Ceftriaxone; Vancomycin

Cevap

The immediate empiric regimen should include ampicillin, ceftriaxone, and vancomycin.
The patient's clinical presentation and cerebrospinal fluid analysis are consistent with acute bacterial meningitis. In adults aged 2 to 50 years, the most common pathogens are Streptococcus pneumoniae and Neisseria meningitidis, and standard empiric therapy includes vancomycin and a third-generation cephalosporin (e.g., ceftriaxone). However, in patients older than 50 years, or those with altered cellular immunity (such as from alcohol use disorder or diabetes), there is an increased risk of infection with Listeria monocytogenes. Therefore, ampicillin must be added to the empiric regimen. The correct multi-drug regimen includes vancomycin, ceftriaxone, and ampicillin.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and cerebrospinal fluid (CSF) findings.
The combination of fever, headache, nuchal rigidity, altered mental status, and a CSF profile with high neutrophils, low glucose, and high protein indicates acute bacterial meningitis.
Establishing the correct diagnosis dictates the choice of empiric antimicrobial therapy.
2
Identify the patient's demographic and medical risk factors.
The patient is over 50 years old (58 years) and has a history of alcohol use disorder and diabetes mellitus.
Age and comorbidities determine the likely causative organisms and the need for expanded antibiotic coverage.
3
Select the appropriate empiric antibiotic regimen based on the identified risk factors.
Vancomycin and ceftriaxone are selected for baseline coverage, while ampicillin is added specifically to cover Listeria monocytogenes.
Standard empiric therapy for adults includes vancomycin and a third-generation cephalosporin. Ampicillin must be added for patients >50 years or those who are immunocompromised.

Anahtar Kavram

Empiric antibiotic therapy for bacterial meningitis in adults >50 years or with immunocompromising conditions (such as alcoholism) requires a combination of vancomycin, a third-generation cephalosporin (e.g., ceftriaxone), and ampicillin.
Soru 103Soru →

A 71-year-old man is evaluated in the intensive care unit for new-onset tachypnea and pleuritic chest pain. He was admitted one week ago for severe community-acquired pneumonia requiring mechanical ventilation, from which he was successfully extubated yesterday. He has a history of severe chronic kidney disease with a baseline glomerular filtration rate of 12 mL/min/1.73 m212 \text{ mL/min/1.73 m}^2, not currently on dialysis. Vital signs today include a heart rate of 115/min115\text{/min}, blood pressure 105/65 mmHg105/65\text{ mmHg}, and oxygen saturation of 90%90\% on room air. A computed tomography scan of the chest with intravenous contrast reveals a saddle pulmonary embolus. An intravenous anticoagulant relying on a highly sulfated glycosaminoglycan to bind an endogenous protease inhibitor is initiated. Four days later, routine laboratory studies reveal a platelet count of 85,000/mm385,000/\text{mm}^3, decreased from a baseline of 210,000/mm3210,000/\text{mm}^3 on admission. No new medications have been added, and physical examination is unremarkable except for mild bilateral lower extremity edema. A specific functional platelet assay returns positive. The initial anticoagulant is immediately discontinued. Based on the patient's underlying comorbidities, which of the following best describes the molecular mechanism of the most appropriate alternative therapy?

Cevabı ve açıklamayı göster

Cevap: Reversible occupancy of the active catalytic site of factor IIa

Cevap

Reversible occupancy of the active catalytic site of factor IIa
The patient has developed Heparin-Induced Thrombocytopenia (HIT), evidenced by a significant drop in platelets following heparin exposure and a positive functional assay (serotonin release assay). Management requires immediate cessation of heparin and initiation of a non-heparin anticoagulant. Because the patient has severe renal impairment (GFR 12 mL/min/1.73 m212 \text{ mL/min/1.73 m}^2), renally cleared agents such as fondaparinux or bivalirudin are contraindicated or require extreme caution. The most appropriate agent is argatroban, which is a hepatically cleared direct thrombin inhibitor. Its mechanism of action is the direct, reversible occupancy of the active catalytic site of factor IIa (thrombin).

Adım Adım Çözüm

1
Diagnose the patient's acute complication based on laboratory trends.
The patient developed a greater than 50% drop in platelet count (from 210,000 to 85,000) four days after starting unfractionated heparin, with a positive functional platelet assay, confirming Heparin-Induced Thrombocytopenia (HIT).
Recognizing HIT is critical because it requires immediate cessation of all heparin-containing products.
2
Determine the required intervention for the confirmed diagnosis.
Initiation of a non-heparin alternative anticoagulant.
HIT is a highly prothrombotic state. Discontinuing heparin is not enough; therapeutic anticoagulation must be maintained to treat the existing pulmonary embolus and prevent new thromboses.
3
Evaluate patient-specific comorbidities that influence drug selection.
The patient has severe chronic kidney disease with a baseline glomerular filtration rate of 12 mL/min/1.73 m212 \text{ mL/min/1.73 m}^2.
Renal clearance is a major pathway for many anticoagulants (e.g., fondaparinux, bivalirudin, LMWH). Severe renal impairment significantly limits these options.
4
Select the optimal pharmacologic agent and identify its mechanism.
Argatroban is the optimal choice because it is hepatically cleared. Its mechanism of action is the reversible occupancy of the active catalytic site of factor IIa (thrombin).
Using a hepatically cleared agent avoids drug accumulation and bleeding toxicity in the setting of end-stage renal disease.

Anahtar Kavram

In patients with Heparin-Induced Thrombocytopenia (HIT) and concurrent severe renal impairment, hepatically cleared direct thrombin inhibitors (such as argatroban) are the anticoagulants of choice.
Tahmini Süre:2m 0s
Soru 104Soru →

A 68-year-old man is admitted to the hospital with a 3-week history of low-grade fevers, chills, and generalized fatigue. He recently underwent a cystoscopy for benign prostatic hyperplasia. On physical examination, his temperature is 38.2°C (100.8°F), and a new holosystolic murmur is heard at the cardiac apex. Blood cultures grow gram-positive cocci in pairs and short chains that are catalase-negative and grow in 6.5% NaCl broth. Transesophageal echocardiography reveals a 1.2-cm vegetation on the mitral valve.

The patient is started on continuous-infusion ampicillin and once-daily gentamicin to achieve synergistic bactericidal activity. Two days later, antimicrobial susceptibility testing results are reported as follows:

Antimicrobial AgentMIC (mcg/mL)Interpretation
Ampicillin2Susceptible
Vancomycin1Susceptible
Gentamicin>500High-level resistance
Streptomycin64Susceptible to synergy

Given these results, gentamicin is discontinued, and ceftriaxone is added to the ampicillin regimen. Which of the following best describes the precise molecular mechanism responsible for the lack of ampicillin-gentamicin synergy in this patient's isolate?

Cevabı ve açıklamayı göster

Cevap: Enzymatic transfer of functional groups to the hydroxyl or amino moieties of the drug

Cevap

The correct mechanism is the enzymatic transfer of functional groups to the hydroxyl or amino moieties of the drug.
The patient has infective endocarditis caused by Enterococcus species. Enterococci possess intrinsic low-level resistance to aminoglycosides due to poor drug penetration across the cell wall. Combining a cell-wall active agent (ampicillin) with an aminoglycoside (gentamicin) allows the aminoglycoside to enter the cell, resulting in bactericidal synergy. However, if the isolate acquires high-level gentamicin resistance (MIC > 500 mcg/mL), synergy is abolished. In enterococci, high-level gentamicin resistance is almost exclusively mediated by the acquisition of mobile genetic elements encoding aminoglycoside-modifying enzymes (AMEs), such as the bifunctional AAC(6')-Ie-APH(2'')-Ia enzyme. These enzymes covalently transfer acetyl, phosphoryl, or adenylyl groups to the amino or hydroxyl moieties of the aminoglycoside, preventing the drug from binding to its target on the 30S ribosomal subunit. Without synergy, an alternative dual beta-lactam bactericidal regimen (such as ampicillin plus ceftriaxone) must be used.

Adım Adım Çözüm

1
Identify the causative pathogen from the clinical and microbiologic description.
The organism is Enterococcus faecalis.
Gram-positive cocci in chains that are catalase-negative and capable of growth in 6.5% NaCl broth are classic laboratory characteristics of enterococci.
2
Analyze the provided minimum inhibitory concentration (MIC) profile.
The isolate is susceptible to ampicillin and vancomycin but exhibits high-level resistance to gentamicin (MIC > 500 mcg/mL) while remaining susceptible to streptomycin synergy (MIC < 1000 mcg/mL).
Understanding the susceptibility profile is required to determine why the initial ampicillin-gentamicin synergy failed.
3
Deduce the molecular mechanism of high-level gentamicin resistance in enterococci.
High-level gentamicin resistance is almost exclusively caused by the acquisition of aminoglycoside-modifying enzymes (AMEs).
Unlike intrinsic low-level resistance (poor cell wall penetration) which is overcome by ampicillin, acquired high-level resistance abolishes synergy.
4
Differentiate gentamicin resistance from streptomycin resistance mechanisms.
Ribosomal target site mutations cause high-level streptomycin resistance, but do not affect gentamicin. Because this isolate is resistant only to gentamicin, AMEs (which covalently modify the drug) must be the responsible mechanism.
Distinguishing between specific aminoglycoside resistance mechanisms is necessary to rule out the distractor involving the 30S ribosomal subunit.

Anahtar Kavram

High-level gentamicin resistance in Enterococcus species is primarily mediated by acquired aminoglycoside-modifying enzymes that covalently alter the drug structure, thereby abolishing the bactericidal synergy normally achieved by combining a cell-wall active agent with an aminoglycoside.
Soru 105Soru →

A 54-year-old woman is evaluated in the intensive care unit for worsening respiratory status. She was admitted 14 days ago for management of extensive third-degree burns covering 40% of her total body surface area. Over the past 24 hours, she has developed a new-onset fever, tachycardia, and increased purulent endotracheal secretions requiring higher ventilator settings. Her temperature is 39.4°C (102.9°F), blood pressure is 90/55 mmHg, and heart rate is 118/min. A Gram stain of the endotracheal aspirate reveals numerous neutrophils and Gram-negative bacilli. The organism is non-lactose-fermenting, oxidase-positive, and produces a blue-green pigment on culture. Antimicrobial susceptibility testing results for the isolate are shown below:

Antimicrobial AgentSusceptibility
CeftazidimeSusceptible
CefepimeSusceptible
CiprofloxacinSusceptible
ImipenemResistant

Which of the following cellular mechanisms best explains this isolate's specific antimicrobial resistance profile?

Cevabı ve açıklamayı göster

Cevap: Mutational loss or downregulation of a specific outer membrane porin channel

Cevap

Mutational loss or downregulation of a specific outer membrane porin channel
The patient has developed a healthcare-associated pneumonia secondary to Pseudomonas aeruginosa. The microbiological description (non-lactose-fermenting, oxidase-positive, Gram-negative rod producing a blue-green pigment) is highly characteristic of this organism. The antimicrobial susceptibility testing reveals a classic pattern: isolated resistance to imipenem with preserved susceptibility to antipseudomonal cephalosporins (ceftazidime, cefepime) and fluoroquinolones. Imipenem is unique among beta-lactams in that it traverses the outer membrane of P. aeruginosa almost exclusively via the OprD porin channel. Consequently, mutational loss, structural alteration, or transcriptional downregulation of OprD prevents imipenem from reaching its target penicillin-binding proteins (PBPs) in the periplasmic space, conferring resistance. Because cephalosporins and other beta-lactams utilize different porins or pathways for entry, they retain their efficacy against OprD-deficient strains.

Adım Adım Çözüm

1
Identify the causative pathogen from the clinical and microbiological data.
The patient has ventilator-associated pneumonia caused by Pseudomonas aeruginosa, evidenced by a non-lactose-fermenting, oxidase-positive Gram-negative bacillus producing a blue-green pigment (pyocyanin) in a burn patient.
Correct identification of the organism is required to interpret species-specific resistance patterns accurately.
2
Analyze the provided antimicrobial susceptibility profile.
The isolate demonstrates isolated resistance to imipenem, while retaining susceptibility to other antipseudomonal beta-lactams (ceftazidime, cefepime) and fluoroquinolones (ciprofloxacin).
Different resistance mechanisms confer distinct phenotypic patterns of antimicrobial susceptibility.
3
Determine the molecular mechanism that explains isolated carbapenem resistance in this specific pathogen.
Imipenem uniquely relies on the OprD outer membrane porin to penetrate the cell envelope of P. aeruginosa. Loss of this porin confers resistance to imipenem while sparing agents that use alternative entry pathways.
Linking the unique phenotypic profile to the precise cellular mechanism identifies the correct answer.

Anahtar Kavram

Isolated imipenem resistance in Pseudomonas aeruginosa is classically mediated by the mutational loss or downregulation of the OprD outer membrane porin channel.
Soru 106Soru →

A 6767-year-old male presents to the primary care clinic for a routine follow-up. Five years ago, he underwent a mechanical mitral valve replacement and has been maintained on chronic warfarin therapy. His target international normalized ratio (INR) is between 2.52.5 and 3.53.5. Over the past year, his laboratory values have been stable on a daily warfarin dose of 55 mg. Six days ago, he was evaluated at an urgent care facility for a suspected urinary tract infection and was prescribed a 77-day course of trimethoprim-sulfamethoxazole. The patient reports feeling well today. He denies any epistaxis, hematuria, melena, or easy bruising. Vital signs are within normal limits. Physical examination reveals clear lungs, normal heart sounds with a distinct mechanical click, and no petechiae or ecchymoses. His neurologic examination is unremarkable. A point-of-care INR obtained in the clinic today is 7.47.4. Which of the following is the most appropriate next step in management of this patient?

Cevabı ve açıklamayı göster

Cevap: Withhold the next one to two doses of warfarin and recheck the laboratory values in 2424 to 4848 hours

Cevap

Withhold the next one to two doses of warfarin and recheck the laboratory values in 2424 to 4848 hours.
This patient has a supratherapeutic INR of 7.47.4 but remains completely asymptomatic without any signs of clinical bleeding. The acute elevation is due to the recent initiation of trimethoprim-sulfamethoxazole, a strong inhibitor of CYP2C9 that decreases the metabolism of S-warfarin. According to standard clinical guidelines, for patients with an INR between 4.54.5 and 10.010.0 and no evidence of bleeding, the recommended management is to simply withhold the next 11 to 22 doses of warfarin, monitor the INR closely, and restart therapy at an appropriately adjusted (lower) dose once the INR returns to the therapeutic range. Routine use of oral vitamin K is not recommended in this specific range due to the risk of overcorrection and subsequent warfarin resistance.

Adım Adım Çözüm

1
Assess the patient's clinical stability and bleeding status.
The patient is completely asymptomatic with no signs of active bleeding or trauma on physical examination.
The presence or absence of major bleeding dictates whether rapid pharmacological reversal is required versus simple dose adjustment.
2
Evaluate the laboratory finding in the context of recent medication changes.
The INR is supratherapeutic at 7.47.4, likely driven by the recent addition of trimethoprim-sulfamethoxazole.
Trimethoprim-sulfamethoxazole inhibits CYP2C9, significantly decreasing warfarin clearance and abruptly increasing the INR.
3
Apply clinical guidelines for warfarin management based on the INR value.
For an INR between 4.54.5 and 10.010.0 without bleeding, guidelines recommend withholding 11 to 22 doses of warfarin and rechecking the INR.
Routine use of vitamin K in this range is advised against because it can cause warfarin resistance once the patient needs to resume anticoagulation.

Anahtar Kavram

Management of supratherapeutic INR without bleeding
Soru 107Soru →

A 42-year-old woman with a history of bipolar I disorder is admitted to the inpatient psychiatric unit with an acute manic episode. She has previously been nonadherent to medications but now agrees to initiate treatment with lithium carbonate. She has no other medical conditions and takes no other medications. Her physical examination is unremarkable. In addition to monitoring serum drug concentrations, which of the following laboratory parameters are necessary to evaluate at baseline and periodically during long-term maintenance therapy with this medication? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Thyroid-stimulating hormone (TSH); Serum calcium; Serum creatinine

Cevap

The correct parameters to monitor are thyroid-stimulating hormone (TSH), serum calcium, and serum creatinine.
Lithium is a mood stabilizer with well-known long-term toxicities affecting the kidneys (nephrogenic diabetes insipidus, chronic tubulointerstitial nephropathy), the thyroid gland (hypothyroidism, goiter), and the parathyroid glands (hyperparathyroidism). Therefore, standard of care dictates that baseline and periodic monitoring include serum creatinine, thyroid-stimulating hormone (TSH), and serum calcium. This ensures early detection and management of these adverse effects.

Adım Adım Çözüm

1
Identify the initiated medication and its pharmacologic profile.
The patient is starting lithium carbonate for bipolar disorder.
Different mood stabilizers have distinct adverse effect profiles requiring specific monitoring strategies.
2
Determine the known long-term adverse effects of lithium.
Lithium is associated with thyroid dysfunction, renal impairment, and hyperparathyroidism.
Baseline and ongoing surveillance must target the organ systems susceptible to toxicity.
3
Select the corresponding laboratory tests.
TSH (thyroid), serum creatinine (kidneys), and serum calcium (parathyroid) are the necessary tests.
These tests detect the most common and clinically significant end-organ complications of lithium therapy.

Anahtar Kavram

Baseline and ongoing monitoring for lithium therapy must include renal function (creatinine), thyroid function (TSH), and serum calcium due to the long-term risks of chronic kidney disease, hypothyroidism, and hyperparathyroidism.
Tahmini Süre:1m 30s
Soru 108Soru →

A 62-year-old male establishes care at a primary care clinic for a persistent, dry cough that has bothered him for the past three months. The patient states the cough often wakes him at night and is not relieved by over-the-counter antitussive syrups. He denies any fever, weight loss, hemoptysis, or shortness of breath. His past medical history is notable for hypertension, hyperlipidemia, and osteoarthritis. Vital signs are within normal limits. Auscultation of the lungs reveals clear breath sounds bilaterally with no wheezes or crackles. Laboratory testing shows an absolute eosinophil count of 350/μL350/\mu L (normal: 15−500/μL15 - 500/\mu L). A recent chest radiograph shows no abnormalities. Which of the following historical inquiries is the most appropriate next step to establish the diagnosis?

Cevabı ve açıklamayı göster

Cevap: Reviewing the patient's active medication list for angiotensin-converting enzyme inhibitors

Cevap

Reviewing the patient's active medication list for angiotensin-converting enzyme inhibitors
The correct answer involves identifying the use of angiotensin-converting enzyme (ACE) inhibitors. The patient presents with a classic chronic, dry cough and a normal cardiopulmonary workup. Given his history of hypertension, an ACE inhibitor is a highly likely culprit. Inhibition of the ACE enzyme prevents the breakdown of bradykinin; its subsequent accumulation in the respiratory tract causes this characteristic cough. Therefore, reviewing the medication history is the most critical and highest-yield next step to establish the diagnosis.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and demographics.
The patient is an older adult with a chronic, dry, non-productive cough, a normal physical examination, a normal chest radiograph, and a history of hypertension.
Identifying the chronicity of symptoms and the lack of structural pulmonary findings helps narrow the differential diagnosis away from infections and malignancies.
2
Evaluate the relationship between the patient's comorbidities and potential iatrogenic causes.
The patient has hypertension, which is frequently managed with angiotensin-converting enzyme (ACE) inhibitors. A classic side effect of ACE inhibitors is a chronic, dry cough.
A thorough medication history is the most cost-effective and direct method to diagnose medication-induced adverse effects before pursuing invasive or expensive testing.

Anahtar Kavram

Medication-induced adverse effects, particularly ACE inhibitor-induced cough, must be evaluated as a primary step in the medical history of patients presenting with chronic cough and a normal chest radiograph.
Soru 109Soru →

During a routine follow-up in the outpatient cardiology clinic, a 48-year-old man complains of worsening abdominal fullness, leg swelling, and generalized fatigue over the last six months. The patient emigrated from India ten years ago and received a prolonged course of multiple antimicrobial agents for a chronic, productive cough when he was in his twenties. He reports no alcohol use. Vital signs include a temperature of 37.0°C (98.6°F), blood pressure of 112/74 mm Hg, and pulse of 94/min. Upon physical examination, the internal jugular veins remain distended while he is seated at a 45-degree angle; observation of the venous column reveals a paradoxical rise when the patient takes a deep breath. Palpation of the anterior chest wall yields an absent apical impulse. Cardiac auscultation reveals normal S1 and S2 sounds, immediately followed by a sharp, high-pitched early diastolic sound at the left sternal border. Lung fields are clear to auscultation bilaterally. Abdominal examination reveals a tense, protuberant contour with shifting dullness. The liver edge is easily palpable 4 cm below the right costal margin. Bilateral lower extremities exhibit 2+ pitting edema extending to the knees. Laboratory evaluation demonstrates a serum albumin of 3.2 g/dL, total bilirubin of 1.8 mg/dL, and aspartate aminotransferase of 62 U/L. Based on these physical examination findings, which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Constrictive pericarditis

Cevap

The correct diagnosis is constrictive pericarditis, evidenced by signs of right heart failure combined with Kussmaul's sign and a classic pericardial knock.
The correct diagnosis is constrictive pericarditis. The physical examination findings are classic for this condition. The paradoxical rise in jugular venous pressure during inspiration is known as Kussmaul's sign, which indicates impaired right ventricular filling. The absent apical impulse is due to the thick, calcified pericardium encasing the heart. The sharp, early diastolic sound is a pericardial knock, occurring due to the sudden cessation of ventricular filling when the expanding ventricle hits the rigid pericardial sac. In a patient from an endemic region with a history of a treated chronic cough, prior pulmonary tuberculosis is the most likely underlying etiology for the chronic pericardial inflammation. The ascites, peripheral edema, and mild hepatic laboratory derangements are all secondary manifestations of congestive hepatopathy caused by the severe right-sided heart failure.

Adım Adım Çözüm

1
Analyze the jugular venous pulse findings.
The JVP is elevated and exhibits a paradoxical rise on inspiration (Kussmaul's sign).
This finding localizes the pathology to impaired right ventricular filling, effectively ruling out primary hepatic disease as the sole cause of the patient's fluid overload.
2
Evaluate the cardiac palpation and auscultation findings.
The patient has an absent apical impulse and a sharp, high-pitched early diastolic sound (pericardial knock).
A pericardial knock is highly specific for the sudden cessation of ventricular filling caused by a thickened, rigid pericardium, distinguishing this condition from the S3 or S4 typically heard in restrictive cardiomyopathy.
3
Synthesize the physical findings with the patient's medical history and laboratory results.
The combination of right-sided heart failure signs, a pericardial knock, and Kussmaul's sign in a patient with a history of treated tuberculosis points directly to constrictive pericarditis.
Chronic inflammation from prior tuberculosis can lead to pericardial calcification. The resulting right-sided heart failure causes secondary congestive hepatopathy, explaining the ascites and mildly elevated liver enzymes.

Anahtar Kavram

Differentiating constrictive pericarditis from other causes of right heart failure using specific physical examination findings such as Kussmaul's sign and a pericardial knock.
Soru 110Soru →

A 48-year-old man presents to the emergency department with an 8-hour history of severe, unremitting epigastric pain that radiates to his mid-back. He reports that the pain is exacerbated by lying supine and is partially relieved by leaning forward. He has had two episodes of non-bloody, non-bilious emesis since the pain began. His medical history is notable for hypertension treated with amlodipine. He does not use tobacco but drinks 3-4 alcoholic beverages daily. His temperature is 37.8∘C37.8^\circ\text{C} (100∘F100^\circ\text{F}), blood pressure is 138/86 mmHg138/86\text{ mmHg}, pulse is 105/min105/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination shows a distressed patient with marked epigastric tenderness to palpation, but no rebound tenderness or guarding. Bowel sounds are hypoactive. Which of the following diagnostic tests should be included in the initial diagnostic workup of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serum lipase measurement; Right upper quadrant abdominal ultrasound

Cevap

The most appropriate initial diagnostic tests for this patient are serum lipase measurement and a right upper quadrant abdominal ultrasound.
The patient's presentation is highly suspicious for acute pancreatitis. The diagnosis of acute pancreatitis is established by the presence of at least two of three criteria: 1) characteristic acute-onset epigastric pain radiating to the back, 2) serum lipase elevation at least three times the upper limit of normal, and 3) characteristic findings on cross-sectional imaging (CT or MRI). Therefore, measuring serum lipase is an essential, non-invasive first step to confirm the diagnosis. Furthermore, because gallstones are the most common cause of acute pancreatitis, a right upper quadrant abdominal ultrasound is universally recommended as part of the initial evaluation in all patients to assess for cholelithiasis or biliary duct dilation.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient has acute-onset, severe epigastric pain radiating to the back, exacerbated by lying flat, along with a history of alcohol use. This is the classic presentation of acute pancreatitis.
Identifying the primary differential diagnosis dictates the required diagnostic criteria.
2
Determine the diagnostic criteria for acute pancreatitis.
Diagnosis requires two of the three following criteria: characteristic abdominal pain, serum lipase elevation (at least 3 times the upper limit of normal), and characteristic findings on cross-sectional imaging.
Guidelines specify that laboratory evaluation is the primary initial adjunct to the clinical history.
3
Select the appropriate initial laboratory and imaging tests.
Serum lipase must be drawn to fulfill diagnostic criteria. Concurrently, right upper quadrant ultrasound must be ordered to evaluate for gallstones, which are the most common cause of acute pancreatitis worldwide.
Initial tests should be highly sensitive, cost-effective, and non-invasive before progressing to advanced imaging or invasive procedures.

Anahtar Kavram

The initial diagnostic workup for suspected acute pancreatitis requires measuring serum lipase to confirm the diagnosis and performing a right upper quadrant abdominal ultrasound to assess for a biliary etiology.
Soru 111Soru →

A 48-year-old woman presents to the emergency department reporting a temperature of 38.4°C (101.1°F) measured at home. She is currently undergoing adjuvant chemotherapy with docetaxel and cyclophosphamide for stage II breast cancer; her last cycle was 10 days ago. She reports mild fatigue but denies chills, cough, dyspnea, abdominal pain, or dysuria. She lives with her husband 15 minutes away from the hospital and has been independently performing all daily activities.

Vital signs on arrival show a blood pressure of 122/78 mmHg, pulse of 88/min, respiratory rate of 14/min, and oxygen saturation of 99% on room air. Physical examination reveals a well-appearing, well-hydrated woman with no focal source of infection. An implanted venous port site shows no erythema or tenderness.

Laboratory studies reveal:
Hemoglobin: 10.5 g/dL
Leukocytes: 800/mm³
Absolute neutrophil count (ANC): 300/mm³
Platelets: 120,000/mm³
Comprehensive metabolic panel: within normal limits

Blood and urine cultures are obtained, and she is promptly given a dose of intravenous cefepime. After 4 hours of observation in the emergency department, she remains afebrile and hemodynamically stable, and she tolerates oral fluids without difficulty. Based on this patient's clinical risk profile and treatment response, which of the following is the most appropriate disposition?

Cevabı ve açıklamayı göster

Cevap: Discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate.

Cevap

Discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate.
The correct disposition for this patient is discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate. This patient has febrile neutropenia, which requires immediate empiric antibiotics. However, she meets the criteria for a low-risk presentation based on objective scoring systems such as the MASCC risk index (score ≥ 21). She is hemodynamically stable, lacks significant comorbidities (like COPD or hypotension), has a solid tumor rather than a hematologic malignancy, is younger than 60, and is experiencing only mild symptoms. Furthermore, she tolerates oral intake, is functionally independent, and has a reliable caregiver living in close proximity to the hospital. Clinical guidelines recommend that such low-risk patients receive an initial prompt dose of intravenous antibiotics in the emergency department, followed by discharge home with broad-spectrum oral antibiotics (usually a fluoroquinolone combined with amoxicillin-clavulanate) and close outpatient follow-up.

Adım Adım Çözüm

1
Identify the primary clinical problem and emergency.
The patient has chemotherapy-induced febrile neutropenia (fever >38.3°C and ANC <500/mm³).
Recognizing the syndrome is required to initiate the appropriate evidence-based clinical pathway.
2
Risk-stratify the patient using an objective severity score.
Calculate the Multinational Association for Supportive Care in Cancer (MASCC) risk index or use Clinical Index of Stable Febrile Neutropenia (CISNE) criteria.
Risk stratification determines whether the patient requires inpatient intravenous therapy or can be managed as an outpatient.
3
Evaluate the objective criteria and functional capacity.
The patient is young (<60), hemodynamically stable, has a solid tumor, no major medical comorbidities, mild symptoms, tolerates oral intake, and has excellent social support (lives with husband near the hospital). She scores >=21 on the MASCC index, placing her in the low-risk category.
Only low-risk patients with intact functional capacity and social support are candidates for outpatient disposition.
4
Determine the optimal disposition setting.
The patient is safely discharged home on empiric oral antibiotics (typically a fluoroquinolone plus amoxicillin-clavulanate) after initial assessment and IV antibiotic dosing in the ED.
This avoids unnecessary hospitalization and minimizes the risk of nosocomial infections while providing definitive care.

Anahtar Kavram

Low-risk febrile neutropenia patients (e.g., MASCC score >=21, hemodynamically stable, no organ dysfunction, tolerating oral intake, reliable social support) should be discharged home on empiric oral broad-spectrum antibiotics rather than being admitted for inpatient intravenous therapy.
Soru 112Soru →

A 68-year-old man is evaluated in the urgent care clinic for a 24-hour history of severe, progressive pain and swelling in his right knee. He is unable to bear weight on the affected leg. His medical history is significant for type 2 diabetes mellitus, hypertension, and stage 4 chronic kidney disease with a baseline estimated glomerular filtration rate (eGFR) of 24 mL/min/1.73 m224 \text{ mL/min/1.73 m}^2. Current medications include amlodipine, insulin detemir, and calcium acetate. Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), pulse 88/min, and blood pressure 138/84 mm Hg. Physical examination reveals a swollen, erythematous, and exquisitely tender right knee with a moderate effusion. Arthrocentesis is performed. Synovial fluid analysis reveals a leukocyte count of 28,000/μL28,000/\mu\text{L} (85% neutrophils) and the presence of negatively birefringent, needle-shaped crystals under polarized light microscopy. Gram stain is negative. Which of the following is the most appropriate pharmacologic intervention for this patient's acute joint condition?

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone

Cevap

Intra-articular triamcinolone is the most appropriate treatment.
Intra-articular triamcinolone is the most appropriate intervention because this patient has an acute monoarticular gout flare combined with severe chronic kidney disease (CKD stage 4). While NSAIDs, colchicine, and systemic/intra-articular glucocorticoids are all first-line options for acute gout in healthy individuals, patient comorbidities dictate the final choice. In severe renal impairment (eGFR <30 mL/min/1.73 m^2), NSAIDs are absolutely contraindicated due to the risk of precipitating acute-on-chronic renal failure. Colchicine should also be avoided due to the high risk of fatal toxicity. For a single accessible inflamed joint, intra-articular glucocorticoids provide rapid, targeted relief with minimal systemic absorption.

Adım Adım Çözüm

1
Interpret the synovial fluid analysis results.
The presence of negatively birefringent, needle-shaped crystals confirms the diagnosis of acute gouty arthritis. The elevated leukocyte count of 28,000/μL is an expected inflammatory response to the crystals.
Establishing a definitive crystal diagnosis eliminates the immediate need for empiric antibiotics despite the highly inflammatory fluid.
2
Review the patient's medical history for contraindications to standard therapies.
The patient has stage 4 chronic kidney disease (eGFR 24 mL/min/1.73 m^2).
Comorbidities dictate the safety profile of acute gout therapies. Standard first-line agents (NSAIDs and colchicine) rely on renal clearance or can directly damage the kidneys.
3
Select the optimal pharmacologic intervention based on the clinical presentation and safety profile.
Intra-articular triamcinolone is selected.
Because the patient has a monoarticular flare (one accessible joint) and severe renal impairment, a local glucocorticoid injection provides excellent efficacy while avoiding the systemic nephrotoxicity of NSAIDs and the systemic neuromyopathy risk of colchicine.

Anahtar Kavram

In patients with acute monoarticular gout and severe chronic kidney disease (eGFR < 30 mL/min/1.73 m^2), NSAIDs and colchicine are contraindicated; intra-articular glucocorticoids are the preferred first-line therapy.
Soru 113Soru →

A 22-year-old male university student is transported to the emergency department after falling approximately 3 meters (10 feet) from a balcony and striking his head on concrete. Emergency medical services report that he was initially conversant at the scene but became increasingly somnolent during transit. Upon arrival, he does not open his eyes to pain, makes no verbal sounds, and withdraws his left arm from painful stimuli. Vital signs demonstrate a blood pressure of 185/105 mmHg, a heart rate of 48/min, and a respiratory rate of 8/min with irregular breathing patterns. Physical examination reveals a right pupil that is 7 mm and unresponsive to light, while the left pupil is 3 mm and briskly reactive. Which of the following is the most appropriate immediate next step in management?

Cevabı ve açıklamayı göster

Cevap: Secure the airway with orotracheal intubation

Cevap

Secure the airway with orotracheal intubation
The most appropriate immediate next step is securing the airway with orotracheal intubation. This patient presents with a severe traumatic brain injury following a 'lucid interval,' classically associated with an epidural hematoma. His Glasgow Coma Scale (GCS) score is 6 (Eyes: 1, Verbal: 1, Motor: 4), and he exhibits clear signs of uncal herniation (ipsilateral fixed and dilated pupil) along with Cushing's triad (hypertension, bradycardia, and irregular respirations). According to standard trauma resuscitation protocols (ATLS), airway maintenance with simultaneous cervical spine protection is the paramount initial step. Any patient with a GCS of 8 or less cannot reliably protect their airway and requires immediate endotracheal intubation to prevent hypoxia and hypercapnia, which would further exacerbate secondary brain injury.

Adım Adım Çözüm

1
Calculate the patient's Glasgow Coma Scale (GCS) score.
The GCS score is 6 (Eyes: 1, Verbal: 1, Motor: 4).
To objectively quantify the level of consciousness and determine the need for airway protection.
2
Analyze the vital signs and pupillary findings.
The patient exhibits Cushing's triad (hypertension, bradycardia, irregular respirations) and an ipsilateral blown pupil.
These findings indicate severely elevated intracranial pressure and impending uncal herniation.
3
Prioritize interventions based on Advanced Trauma Life Support (ATLS) protocols.
Airway protection is identified as the absolute first priority.
A patient with a GCS of 8 or less cannot reliably protect their airway, making intubation the paramount first step before any diagnostic testing or secondary interventions.

Anahtar Kavram

In patients with severe traumatic brain injury (GCS of 8 or less), securing a definitive airway is the absolute first priority in the primary survey, preceding diagnostic imaging or medical management of intracranial pressure.
Soru 114Soru →

A 54-year-old woman presents to the emergency department after recording a temperature of 38.5°C (101.3°F) at home two hours ago. She has a history of stage II right breast cancer and underwent a lumpectomy six weeks ago. She is currently receiving adjuvant chemotherapy, with her most recent cycle of docetaxel and cyclophosphamide administered 8 days ago. The patient reports mild fatigue but denies chills, cough, shortness of breath, dysuria, abdominal pain, or diarrhea. She has no other significant medical conditions. She lives 10 miles from the hospital with her husband, who drove her to the emergency department today.

Temperature is 38.3°C (100.9°F), blood pressure is 122/78 mm Hg, pulse is 92/min, and respiratory rate is 16/min. Pulse oximetry is 99% on room air. The patient appears comfortable and in no acute distress. The implanted central venous catheter site is clean without erythema, induration, or tenderness. Cardiopulmonary examination is normal. The abdomen is soft and non-tender.

Laboratory studies show:
Leukocyte count: 1,100/µL
Absolute neutrophil count: 350/µL
Hemoglobin: 11.2 g/dL
Platelets: 145,000/µL
Blood urea nitrogen: 14 mg/dL
Serum creatinine: 0.8 mg/dL
Hepatic function panel: Normal

Chest radiograph shows no infiltrates. Urinalysis is unremarkable. The patient is able to tolerate oral fluids in the emergency department without nausea.

Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge to home with oral ciprofloxacin and amoxicillin-clavulanate

Cevap

Discharge to home with oral ciprofloxacin and amoxicillin-clavulanate
The correct disposition is to discharge the patient home with oral antibiotics. This patient presents with febrile neutropenia, defined as a single oral temperature of ≥\geq 38.3°C (101°F) and an absolute neutrophil count (ANC) <500< 500/µL. While febrile neutropenia is an oncologic emergency, not all patients require inpatient admission. Risk stratification using validated tools, such as the Multinational Association for Supportive Care in Cancer (MASCC) risk index or the Clinical Index of Stable Febrile Neutropenia (CISNE), helps determine the appropriate care setting. This patient is considered low-risk because she has no significant medical comorbidities, is hemodynamically stable, lacks focal signs of infection (e.g., pneumonia, port infection), is able to tolerate oral intake, and has reliable social support and transportation. According to current guidelines, low-risk patients can be safely discharged home with oral empiric antibiotics. The standard outpatient regimen is a fluoroquinolone (e.g., ciprofloxacin or levofloxacin) plus amoxicillin-clavulanate to provide necessary broad-spectrum coverage, crucially including coverage against Pseudomonas aeruginosa.

Adım Adım Çözüm

1
Diagnose the acute condition based on vital signs and laboratory results.
The patient has febrile neutropenia, defined by a temperature ≥\geq 38.3°C and an absolute neutrophil count (ANC) <500< 500/µL.
Identifying febrile neutropenia is critical as it is an oncologic emergency requiring prompt empiric antibiotics.
2
Risk stratify the patient using clinical criteria (e.g., MASCC or CISNE score) to determine the risk of serious complications.
The patient is classified as low-risk.
She has a solid tumor, is hemodynamically stable, lacks medical comorbidities, has no focal site of infection, tolerates oral intake, and has reliable social support.
3
Determine the appropriate care setting and empiric antibiotic regimen for a low-risk patient.
Discharge home with an oral fluoroquinolone (e.g., ciprofloxacin) plus amoxicillin-clavulanate.
Low-risk patients do not require hospitalization and can be safely managed as outpatients with oral antibiotics that provide broad-spectrum coverage, specifically including Pseudomonas aeruginosa.

Anahtar Kavram

Patients with low-risk febrile neutropenia (solid tumor, hemodynamically stable, no comorbidities, tolerating PO, good social support) should be discharged home with empiric oral antibiotics (e.g., a fluoroquinolone plus amoxicillin-clavulanate) rather than being admitted for intravenous therapy.
Soru 115Soru →

A 58-year-old man is evaluated in the hospital for a 5-day history of fever, nonproductive cough, and right-sided pleuritic chest pain. He underwent a deceased-donor renal transplantation eight months ago and is maintained on a daily immunosuppressive regimen of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Vital signs are temperature 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), pulse 108/min108/\text{min}, respirations 20/min20/\text{min}, and blood pressure 138/82 mm Hg138/82\text{ mm Hg}. Chest computed tomography reveals a dense right upper lobe nodule with a surrounding halo of ground-glass attenuation. Serum galactomannan assay is strongly positive, and bronchoscopy with bronchoalveolar lavage confirms the diagnosis of invasive pulmonary aspergillosis. The medical team decides to initiate the standard first-line targeted intravenous antifungal therapy for this condition. Which of the following concurrent pharmacologic interventions is most appropriate for this patient?

Cevabı ve açıklamayı göster

Cevap: Decrease the current dosage of tacrolimus

Cevap

Decrease the current dosage of tacrolimus
This patient has a confirmed diagnosis of invasive pulmonary aspergillosis (IPA), indicated by the halo sign on CT and positive galactomannan. The standard-of-care targeted pharmacologic intervention is voriconazole. Voriconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) isoenzyme. Tacrolimus, a calcineurin inhibitor crucial for preventing renal allograft rejection, has a narrow therapeutic index and is heavily metabolized by CYP3A4 in the liver and intestines. Concurrent initiation of voriconazole will dramatically reduce tacrolimus clearance, leading to toxic serum trough levels. This toxicity typically manifests as severe acute kidney injury (which is especially dangerous in a renal transplant recipient), hypertension, and neurologic complications such as seizures or posterior reversible encephalopathy syndrome (PRES). To safely manage this patient, the clinician must preemptively decrease the dosage of tacrolimus (often by 30% to 50%) when starting voriconazole and rigorously monitor serum trough levels.

Adım Adım Çözüm

1
Identify the primary diagnosis and the standard-of-care medication required.
The patient has invasive pulmonary aspergillosis (IPA). The first-line targeted pharmacologic therapy is intravenous voriconazole.
Establishing the specific antimicrobial required is necessary to evaluate its impact on the patient's complex baseline medication regimen.
2
Analyze the pharmacokinetic profile of the intended treatment against the patient's active medication list.
Voriconazole is a strong inhibitor of the hepatic cytochrome P450 3A4 (CYP3A4) enzyme system. The patient is taking tacrolimus, which is extensively metabolized by CYP3A4.
Identifying drug-drug interactions is critical in transplant patients to prevent organ rejection or drug toxicity.
3
Determine the necessary dosage adjustment based on the interaction.
Because voriconazole will inhibit the clearance of tacrolimus, the serum concentration of tacrolimus will rise significantly. The tacrolimus dose must be preemptively decreased (often by 1/3 to 1/2) and blood trough levels monitored closely.
Failure to reduce the dose will lead to acute calcineurin-inhibitor toxicity, manifesting as acute kidney injury, tremor, or seizures.

Anahtar Kavram

Initiation of voriconazole (a strong CYP3A4 inhibitor) for invasive aspergillosis requires a preemptive dose reduction of calcineurin inhibitors (like tacrolimus or cyclosporine) to prevent life-threatening drug toxicity.
Tahmini Süre:1m 30s
Soru 116Soru →

A 68-year-old man is preparing for discharge to a subacute rehabilitation facility following a prolonged hospitalization for acute decompensated heart failure and superimposed hospital-acquired pneumonia. His clinical course necessitated numerous changes to his baseline diuretic, antihypertensive, and diabetic regimens. The discharging physician is executing the formal medication reconciliation process to ensure safe continuity of care and prevent adverse drug events during this care transition. Arrange the following fundamental steps of the standardized medication reconciliation process in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for medication reconciliation is: 1) Acquire pre-admission history, 2) Review inpatient medications, 3) Cross-reference lists for discrepancies, 4) Resolve discrepancies clinically, and 5) Transmit the finalized regimen.
The Institute for Healthcare Improvement (IHI) and The Joint Commission mandate a standardized 5-step medication reconciliation process during transitions of care. The chronological process must strictly begin with obtaining the Best Possible Medication History (pre-admission list), followed by reviewing the current hospital medications. These two independent lists are then systematically cross-referenced to identify discrepancies (e.g., missing chronic medications, unintended duplications). The physician then uses clinical judgment to resolve these discrepancies and create a definitive discharge list. Finally, this accurate, finalized list must be formally communicated to the receiving facility (or primary care provider) and the patient to ensure safe continuity of care.

Adım Adım Çözüm

1
Establish the patient's baseline regimen.
Creation of the Best Possible Medication History (pre-admission list).
It is impossible to identify medication omissions or unintended changes without knowing the exact starting point.
2
Identify all current acute therapies.
Compilation of the inpatient medication list.
This is necessary to understand what therapies were added, discontinued, or modified during the hospitalization.
3
Compare the baseline list with the acute therapy list.
Identification of any medication discrepancies.
This systematic comparison highlights unintended omissions of chronic medications or inappropriate continuations of acute-only treatments.
4
Apply clinical decision-making to the discrepancies.
Formulation of the finalized discharge medication regimen.
Ensures that the final list is medically appropriate for the patient's current post-acute stability and ongoing chronic needs.
5
Communicate the final regimen to the next care setting.
Safe transition of care and implementation of the correct treatments.
Prevents administration errors, adverse drug events, and readmissions caused by communication failures at the receiving facility.

Anahtar Kavram

Medication reconciliation during care transitions is a structured, standardized five-step process designed to prevent adverse drug events by systematically identifying and resolving medication discrepancies before patient handoffs.
Soru 117Soru →

A 2828-year-old man is admitted to the intensive care unit with diabetic ketoacidosis. He is initially started on a continuous intravenous regular insulin infusion and 0.9%0.9\% normal saline. Over the next several hours, his blood glucose decreases from 550550 mg/dL to 220220 mg/dL. However, his calculated anion gap remains elevated at 1818 mEq/L, and his serum bicarbonate is 1414 mEq/L. He is clinically stable, and his mental status is improving.

Arrange the following subsequent management and monitoring steps in the correct chronological order to safely resolve the ketoacidosis and transition his therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first add dextrose to the IV fluids, then verify resolution of the anion gap, administer subcutaneous insulin, maintain a 11- to 22-hour overlap with the IV insulin, and finally discontinue the IV insulin.
The chronological management of diabetic ketoacidosis (DKA) focuses first on clearing ketoacids, which requires continuous insulin. When glucose falls below 200200-250250 mg/dL but the anion gap remains elevated, dextrose must be added to the IV fluids so insulin can be continued without causing hypoglycemia. Once the anion gap closes (≤12\leq 12 mEq/L), DKA is considered resolved. At this point, if the patient can tolerate oral intake, subcutaneous insulin is administered. Because IV insulin has a half-life of only a few minutes and subcutaneous insulin requires 11-22 hours for systemic absorption, the IV infusion must be continued for a 11- to 22-hour overlap period. Only after this overlap can the IV insulin be safely discontinued. Failing to overlap correctly is a major cause of rebound DKA in the hospital setting.

Adım Adım Çözüm

1
Evaluate the current metabolic parameters and adjust intravenous fluids.
Recognize that blood glucose has dropped below 250250 mg/dL but ketoacidosis persists (anion gap >12> 12 mEq/L). Dextrose is added to the IV fluids to prevent hypoglycemia while maintaining the insulin drip.
Continuous insulin is required to halt lipolysis and clear ketones; it cannot be stopped or significantly decreased based solely on glucose levels.
2
Monitor serial laboratory values until metabolic resolution is achieved.
Confirm that the anion gap has closed (≤12\leq 12 mEq/L) and bicarbonate has normalized (≥15\geq 15 mEq/L).
This indicates the underlying ketoacidosis has resolved, allowing for the safe transition to maintenance therapy.
3
Initiate the transition to subcutaneous insulin.
Administer a dose of long-acting subcutaneous basal insulin.
Subcutaneous insulin must be on board before the IV insulin is withdrawn to maintain basal metabolic control.
4
Overlap therapies to ensure continuous insulin coverage.
Continue the IV regular insulin infusion for 11 to 22 hours after the subcutaneous injection.
Subcutaneous insulin has a delayed onset of action. An overlap prevents a period of absolute insulin deficiency that could trigger rebound ketoacidosis.
5
Finalize the transition.
Discontinue the IV regular insulin infusion.
The subcutaneous insulin has now reached therapeutic levels, providing safe and continuous coverage.

Anahtar Kavram

Successful management of diabetic ketoacidosis requires maintaining an insulin infusion until the anion gap closes (adding dextrose if glucose falls prematurely) and ensuring a 11- to 22-hour overlap when transitioning to subcutaneous insulin to prevent rebound ketoacidosis.
Soru 118Soru →

Assign the most appropriate guideline-directed next step in the diagnostic sequence for each of the following patients presenting with clinical indicators of secondary hypertension.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 34-year-old woman evaluated for new-onset blood pressure of 165/105 mmHg, accompanied by recurrent headaches and pulsatile tinnitus. Physical examination reveals a right-sided cervical bruit. Her basic metabolic panel is unremarkable.
A 48-year-old man with persistently elevated blood pressure (158/98 mmHg) despite adherence to a regimen of amlodipine, lisinopril, and chlorthalidone. Laboratory evaluation shows a serum potassium of 3.2 mEq/L, a plasma aldosterone concentration of 28 ng/dL, and a plasma renin activity of 0.2 ng/mL/h.
A 55-year-old woman reporting paroxysmal episodes of severe diaphoresis, palpitations, and blood pressure spikes. Biochemical screening indicates 24-hour urine fractionated metanephrines that are five times the upper limit of normal.
A 62-year-old man with established primary hyperaldosteronism, confirmed via an oral sodium loading test, who is being evaluated for surgical intervention. An adrenal-protocol computed tomography scan demonstrates a 1.2 cm nodule in the right adrenal gland and a 1.4 cm nodule in the left adrenal gland.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match the 34-year-old woman with CTA of the renal arteries; the 48-year-old man with the intravenous isotonic saline infusion test; the 55-year-old woman with an MRI of the abdomen; and the 62-year-old man with bilateral adrenal venous sampling.
The correct diagnostic sequencing in secondary hypertension relies on a tiered approach: 1) Clinical or basic laboratory suspicion triggers targeted screening. 2) Positive screening for endocrine causes (like primary aldosteronism) requires definitive biochemical confirmation. 3) Following confirmation, anatomical localization (imaging) is performed. 4) If imaging is equivocal or shows bilateral disease in a surgical candidate, functional lateralization (e.g., venous sampling) is required. Vascular causes like FMD bypass endocrine testing and proceed directly to vascular imaging (CTA/MRA).

Adım Adım Çözüm

1
Evaluate the 34-year-old woman with bruits and tinnitus.
Identify high pre-test probability for Fibromuscular Dysplasia (FMD).
Vascular abnormalities in FMD require direct visualization of the renal arteries via CTA or MRA to assess for stenosis.
2
Analyze the 48-year-old man's hypokalemia and elevated aldosterone-to-renin ratio (ARR).
Identify a positive screening test for primary hyperaldosteronism.
Guidelines mandate biochemical confirmation (e.g., saline suppression test) before imaging, due to the high prevalence of non-secreting adrenal incidentalomas.
3
Assess the 55-year-old woman with elevated metanephrines.
Confirm the diagnosis of pheochromocytoma.
Once the biochemical diagnosis is definitively established, anatomical localization with abdominal MRI or CT is the next sequential step.
4
Review the 62-year-old man's confirmed hyperaldosteronism and bilateral nodules.
Identify the need to differentiate bilateral hyperplasia from a unilateral adenoma.
Because adrenal incidentalomas are common in older adults, bilateral adrenal venous sampling is necessary to confirm functional lateralization before considering unilateral adrenalectomy.

Anahtar Kavram

Strict adherence to diagnostic sequencing in secondary hypertension prevents premature closure and inappropriate surgical interventions, specifically by ensuring biochemical confirmation precedes anatomical imaging, and functional lateralization precedes surgery.

Alternatif Yöntem

For the patient with suspected primary hyperaldosteronism, an oral sodium loading test, fludrocortisone suppression test, or captopril challenge test are valid physiological alternatives to the intravenous saline infusion test for biochemical confirmation.
Tahmini Süre:2m 30s
Soru 119Soru →

A 74-year-old man is evaluated in the intensive care unit 24 hours after admission for a head injury sustained in a ground-level fall. His past medical history is significant for paroxysmal atrial fibrillation, heart failure with preserved ejection fraction, hypertension, and osteoarthritis. His home medications include dabigatran, amiodarone, lisinopril, and meloxicam.

On arrival yesterday, his Glasgow Coma Scale (GCS) score was 14. A noncontrast CT of the head revealed a 6-mm acute right-sided subdural hematoma without midline shift. Initial laboratory studies showed an activated partial thromboplastin time (aPTT) of 68 seconds (reference: 25-35 seconds) and a serum creatinine of 1.6 mg/dL (baseline 1.1 mg/dL). He was promptly administered 5 g of intravenous idarucizumab. A repeat head CT performed 6 hours post-admission showed no expansion of the hematoma.

Currently, the patient is alert and oriented (GCS 15) with no focal neurological deficits. His blood pressure is 132/84 mm Hg, and his pulse is 72/min and irregularly irregular.

Morning laboratory results are as follows:
Hemoglobin: 12.1 g/dL (unchanged from admission)
Platelet count: 185,000/mm³
Serum creatinine: 1.4 mg/dL
Prothrombin time: 13 seconds
Activated partial thromboplastin time (aPTT): 46 seconds

Which of the following is the most appropriate next step in the management of this patient's anticoagulation status?

Cevabı ve açıklamayı göster

Cevap: Continue clinical observation and serial neurological examinations

Cevap

Continue clinical observation and serial neurological examinations.
The correct answer is to continue clinical observation and serial neurological examinations. This patient presented with a life-threatening acute subdural hematoma while taking dabigatran, a direct thrombin inhibitor. The initial administration of idarucizumab, a humanized monoclonal antibody fragment that binds dabigatran with high affinity, successfully neutralized the plasma anticoagulant effect and halted hematoma expansion. At 24 hours post-administration, the patient is clinically stable with an unchanged hemoglobin and a normal neurological examination. The newly elevated aPTT of 46 seconds represents a well-documented phenomenon of 'rebound anticoagulation.' Because dabigatran has a large volume of distribution, extravascular drug slowly redistributes back into the plasma after the initial plasma pool is neutralized by idarucizumab. This redistribution often causes a prolonged aPTT or dilute thrombin time 12 to 24 hours after the reversal agent is given. However, routine re-administration of idarucizumab is not recommended for isolated laboratory rebound; a second dose is only indicated if the patient develops recurrent, life-threatening bleeding or requires an emergent surgical intervention. Careful clinical monitoring is the standard of care.

Adım Adım Çözüm

1
Assess the patient's current clinical stability and bleeding status.
The patient has a stable Glasgow Coma Scale of 15, no hematoma expansion on the 6-hour interval CT, and stable hemoglobin levels.
Clinical status determines whether abnormal coagulation tests represent a risk of future bleeding or active, ongoing hemorrhage requiring immediate intervention.
2
Evaluate the 24-hour laboratory parameters in the context of recent idarucizumab administration.
The aPTT has rebounded to 46 seconds (elevated from normal, but lower than the admission value of 68 seconds).
Understanding the pharmacokinetics of idarucizumab is required to interpret this lab value correctly.
3
Correlate the pharmacokinetic principles of dabigatran and its reversal agent.
Dabigatran has a large volume of distribution. Idarucizumab clears dabigatran from the plasma, but extravascular dabigatran can redistribute back into the plasma 12 to 24 hours later, causing a rebound prolongation of aPTT or thrombin time.
This confirms that the prolonged aPTT is an expected physiological redistribution rather than failure of the initial reversal.
4
Determine the appropriate management for an asymptomatic lab abnormality in this setting.
No further pharmacologic reversal is indicated; supportive care and serial monitoring should be maintained.
Treating a rebound laboratory value in the absence of clinical bleeding exposes the patient to unnecessary medical interventions and potential prothrombotic risks.

Anahtar Kavram

Following dabigatran reversal with idarucizumab, redistribution of extravascular dabigatran back into the systemic circulation commonly causes a rebound prolongation of the aPTT and thrombin time at 12 to 24 hours; in the absence of active bleeding, this isolated laboratory finding requires only clinical observation.
Soru 120Soru →

Review the following four patients currently undergoing evaluation in the emergency department. Utilizing standard objective clinical risk stratification pathways, match each patient's clinical presentation to their most appropriate initial disposition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

74-year-old patient presenting with a productive cough and fever. Examination reveals disorientation to time. Vital signs show a blood pressure of 85/50 mm Hg, heart rate of 110/min, and respiratory rate of 32/min. Laboratory results include a blood urea nitrogen of 28 mg/dL.
48-year-old patient presenting with intermittent, pressure-like chest pain. Past medical history is significant for hypertension. Electrocardiogram reveals 1-mm T-wave inversions in leads II, III, and aVF. Initial high-sensitivity troponin assay is within normal limits.
52-year-old patient diagnosed with an acute segmental pulmonary embolism via computed tomography angiography. Vital signs are stable, including an oxygen saturation of 97% on room air. The patient has no history of cardiopulmonary disease or malignancy.
66-year-old patient presenting with two episodes of melena. Vital signs show a blood pressure of 115/75 mm Hg and heart rate of 105/min. Laboratory results reveal a hemoglobin of 9.2 g/dL and blood urea nitrogen of 35 mg/dL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patients are best assigned as follows: the patient with pneumonia to the Intensive Care Unit, the patient with chest pain to the Clinical Observation Unit, the patient with pulmonary embolism to home discharge, and the patient with a gastrointestinal bleed to the General Medical Ward.
Correct disposition requires matching the objective severity of a patient's illness with the capabilities of a specific care setting. The Intensive Care Unit is reserved for patients with impending physiologic collapse (CURB-65 of 5). The Clinical Observation Unit safely houses moderate-risk patients needing brief, protocolized workups (HEART score of 4). Home discharge is optimized for patients whose acute pathology is stable and manageable with oral regimens (sPESI of 0). The General Medical Ward is utilized for patients requiring inpatient interventions who are not in immediate threat of hemodynamic collapse (stable upper gastrointestinal bleed).

Adım Adım Çözüm

1
Calculate the CURB-65 score for the 74-year-old patient with pneumonia.
The score is 5, indicating high severity.
To identify the need for critical care due to a high mortality risk associated with severe community-acquired pneumonia and active hypotension.
2
Calculate the HEART score for the 48-year-old patient with chest pain.
The score is 4, placing the patient in a moderate-risk category.
To prevent premature discharge of a patient who requires serial monitoring and potentially further ischemic evaluation.
3
Evaluate the 52-year-old patient with a pulmonary embolism using the simplified PESI criteria.
The sPESI score is 0, indicating low risk.
To safely avoid unnecessary hospitalization for a stable patient who can be managed outpatient with oral anticoagulation.
4
Calculate the Glasgow-Blatchford Score for the 66-year-old patient with a gastrointestinal bleed.
The score is elevated, requiring admission, but the patient remains hemodynamically stable.
To ensure the patient receives necessary inpatient endoscopic evaluation while avoiding over-utilization of the ICU.

Anahtar Kavram

Objective risk stratification scores (e.g., CURB-65, HEART, sPESI, Glasgow-Blatchford) guide safe and resource-efficient care setting transitions from the emergency department.
ÖncekiSayfa 6 / 237Sonraki